Journal Guides7 min readUpdated Mar 24, 2026

Nature Medicine APC and Open Access: Same Price as Nature, Different Editorial Game

Nature Medicine charges $12,850 for open access. Same pricing as Nature flagship. Read & Publish deals, waivers, and how it compares to The Lancet and NEJM.

Senior Researcher, Oncology & Cell Biology

Author context

Specializes in manuscript preparation and peer review strategy for oncology and cell biology, with deep experience evaluating submissions to Nature Medicine, JCO, Cancer Cell, and Cell-family journals.

Next step

Choose the next useful decision step first.

Use the guide or checklist that matches this page's intent before you ask for a manuscript-level diagnostic.

Open Journal Fit ChecklistAnthropic Privacy Partner. Zero-retention manuscript processing.Run Free Readiness Scan

Quick answer: Nature Medicine charges $12,850 for gold open access, the exact same price as the Nature flagship. It's a hybrid journal, so subscription-track publication costs nothing. The good news is that Springer Nature's extensive Read & Publish network covers Nature Medicine, meaning most researchers at participating institutions won't pay out of pocket.

The price tag

Nature Medicine's APC mirrors the Nature flagship exactly:

Currency
Amount
USD
$12,850
EUR
€10,850
GBP
£9,390

Springer Nature uses a unified pricing tier for its "Nature Research" titles. Nature, Nature Medicine, Nature Genetics, Nature Biotechnology, Nature Cell Biology, and about 30 other titles in the portfolio all share this same APC. The price is set at the date of acceptance, not submission.

This means a paper that takes 14 months from first submission to final acceptance will be charged the rate in effect when the accept decision drops. If Springer Nature raises prices during your review cycle, you pay the new rate. In practice, Springer Nature has held this tier steady since 2024, but it's worth knowing the rule.

Why it costs as much as Nature

Researchers sometimes find it surprising that Nature Medicine costs the same as Nature itself. Nature has a higher impact factor (57.3 vs. 50.0) and broader name recognition. So why the identical APC?

The answer is business structure, not editorial prestige. Springer Nature prices its titles by portfolio tier, not by individual journal metrics. All "Nature Research" journals sit in the top tier at $12,850. Nature Communications, which is fully gold OA, has its own separate pricing at $7,350. And the "Communications" branded journals (Communications Biology, Communications Medicine) sit at $5,890.

This tier system means that Nature Medicine, Nature Genetics, and Nature Immunology all cost the same to publish OA, despite having different impact factors. The pricing reflects the brand, not the specific journal.

Subscription track: publish for free

Nature Medicine is hybrid. The two publication routes:

  1. Subscription track (default, $0): Your article is published behind the paywall. Library subscribers have access. You pay nothing.
  2. Gold OA track ($12,850): Immediate free access for all readers under a Creative Commons license.

Most Nature Medicine articles are read by researchers at institutions that subscribe. The journal's readership is concentrated in medical schools, research hospitals, and pharma R&D departments. These institutions almost universally have Springer Nature subscriptions.

The practical implication: even behind the paywall, your paper reaches the people who need to read it. Open access matters most for reaching readers outside the traditional subscriber base, including clinicians in low-resource settings, patient advocates, journalists, and policymakers.

Read & Publish agreements: broad coverage

This is where Nature Medicine has a major advantage over competitors like NEJM, The Lancet, or Cancer Cell. Springer Nature's Read & Publish network is the largest in academic publishing.

Region / Consortium
Coverage
Notes
UK (Jisc)
All UK universities
Covers Nature Medicine and 38 other Nature Research titles
Germany (DEAL)
All German research institutions
Springer Nature DEAL agreement, renewed through 2028
Netherlands (UKB)
Dutch universities
Full Nature Portfolio coverage
Austria (KEMOE)
Austrian universities
Active agreement
Sweden (Bibsam)
Swedish universities
Covers Springer Nature hybrid titles
Australia (CAUL)
Australian universities
Capped allocation shared across institutions
United States
Varies by institution
No national consortium; individual university deals

The process is seamless when it works. After acceptance, the Springer Nature system detects your institutional affiliation during production. If your institution has an active agreement, the APC is automatically covered. You simply confirm you want open access, and the system handles the rest.

The US remains the biggest gap. There's no national US deal with Springer Nature. MIT, the UC system, Stanford, and several other large research universities have individual agreements. But many mid-size US institutions don't. If you're at a US university, check your library's open access page before assuming coverage.

Waivers and discounts

Springer Nature applies the same waiver framework across all its journals, including Nature Medicine:

Automatic waivers:

  • Full APC waiver for corresponding authors at institutions in Research4Life Group A countries (low-income nations per World Bank classification).
  • 50% discount for corresponding authors in Group B countries (lower-middle-income nations).

Case-by-case waivers:

  • Authors facing genuine financial hardship can request a waiver at acceptance.
  • Approval isn't guaranteed. Springer Nature reviews circumstances individually.
  • Editorial decisions are firewalled from waiver requests. Editors don't know whether you've applied for a waiver.

Institutional membership discounts:

  • Rare for Nature Research titles. Small discounts (5-15%) are more common on Springer-branded journals than on Nature-branded ones.

The waiver system works well for researchers in low-income countries. For researchers at funded institutions in high-income countries, Springer Nature expects institutional agreements or grant funding to cover the cost.

Funder mandate compliance

Funder/Policy
Compliant?
Route
Plan S (cOAlition S)
Yes
Gold OA with CC BY ($12,850)
NIH Public Access
Yes
Gold OA or green OA (accepted manuscript in PMC after 6-month embargo, $0)
UKRI
Yes
Gold OA with CC BY
ERC
Yes
Gold OA with CC BY
Wellcome Trust
Yes
Gold OA with CC BY
HHMI
Yes
Gold OA with CC BY

Nature Medicine supports both CC BY and CC BY-NC licenses. Plan S mandates CC BY. If your funder is a cOAlition S member, select CC BY during the licensing stage. Getting this wrong and needing to change post-publication is a slow, painful process.

For NIH-funded work, the green OA route is free: publish via subscription, then deposit the accepted manuscript in PubMed Central after 6 months. Nature Medicine's embargo period (6 months) is shorter than JAMA or The Lancet (12 months each), making the green route more practical here.

How Nature Medicine compares to peer journals

Journal
APC (USD)
Model
IF (2024)
Institutional Deals
Embargo
Nature Medicine
$12,850
Hybrid
50.0
Extensive (1,000+ R&P)
6 months
NEJM
~$10,000
Hybrid
78.5
Very limited
6 months
The Lancet
~$6,500
Hybrid
88.5
Limited (excluded from most Elsevier deals)
12 months
JAMA
~$5,500
Hybrid
55.7
Growing
12 months
Cell
$11,400
Hybrid
45.5
Limited (excluded from most Elsevier deals)
12 months

Nature Medicine's listed APC is the highest in this group. But the practical cost to individual researchers is often the lowest, because Read & Publish coverage is so much broader. A UK researcher publishing in Nature Medicine pays $0 for OA through the Jisc agreement. The same researcher publishing in The Lancet may need to find $6,500, because Lancet titles are excluded from most Elsevier transformative agreements.

This is the key insight for researchers comparing journals on cost: the listed APC tells you the sticker price. The actual cost depends on your institution's agreements. Nature Medicine's sticker price is high, but its effective cost is zero for a large proportion of the global research community.

What Nature Medicine publishes

Understanding what Nature Medicine accepts helps contextualize whether the APC question will even apply to you. The journal focuses on:

  • Translational research that bridges basic science and clinical medicine
  • Clinical trials with novel design or practice-changing results
  • Disease mechanism studies with direct therapeutic implications
  • Genomic medicine and precision health
  • Public health research with global significance

Nature Medicine desk-rejects approximately 75-80% of submissions. The editors look for work that moves beyond incremental advances. A well-designed clinical trial in a niche subspecialty might be excellent science but still get desk-rejected because it doesn't fit Nature Medicine's scope of broad translational significance.

The journal published roughly 200-250 original research articles in 2024. With thousands of submissions annually, the math is stark.

Hidden costs

Nature Medicine doesn't charge page fees, submission fees, color figure fees, or overlength charges. The APC is the only publication cost if you choose OA. But these adjacent costs catch people:

  • Tax: In some jurisdictions (particularly the EU), VAT applies on top of the APC. This can add 15-25% to the listed price. A $12,850 APC becomes $14,800-$16,000 with EU VAT.
  • License mistakes: Selecting CC BY-NC when your funder requires CC BY doesn't just create compliance issues. It can delay your paper's appearance in funder-mandated repositories.
  • Embargo deposits: If you publish via subscription and need to deposit in PMC, you're responsible for uploading the accepted manuscript. Springer Nature doesn't automatically deposit in all repositories.
  • Extended data costs: Large supplementary datasets may need to be deposited in external repositories like Figshare or Dryad. These are free for most file sizes but can incur fees for very large datasets (>20 GB).
  • Revision cycles: Long revision periods don't increase the APC, but they can push your acceptance date past the end of your grant period. If your grant closes before acceptance, the APC may need to come from a different funding source.

The practical decision

If Nature Medicine accepts your paper, the APC decision follows a clear path:

  1. Check institutional coverage first. If your institution has a Springer Nature Read & Publish deal, the APC is covered automatically. Choose OA.
  2. Funder requires immediate OA? If yes and no institutional deal, pay $12,850 from grant funds. Most Plan S funders consider this an eligible expense.
  3. NIH-funded, no immediate OA mandate? Publish via subscription (free). Deposit in PMC after 6 months.
  4. No mandate, no deal? Publish via subscription. Nature Medicine's subscriber base ensures your paper reaches the translational and clinical research community.

The APC is secondary to the acceptance decision. Nature Medicine is one of the most selective journals in biomedicine. Before worrying about publication costs, make sure your manuscript fits the journal's scope and meets its bar for translational significance. Run a free readiness scan to identify gaps in your paper's framing, structure, and positioning before you submit.

For the latest fee schedule and agreement details, check Springer Nature's official APC page for Nature Medicine.

Reference library

Use the core publishing datasets alongside this guide

This article answers one part of the publishing decision. The reference library covers the recurring questions that usually come next: how selective journals are, how long review takes, and what the submission requirements look like across journals.

Open the reference library

Before you upload

Want the full picture on Nature Medicine?

Scope, selectivity, what editors want, common rejection reasons, and submission context, all in one place.

These pages attract evaluation intent more than upload-ready intent.

Anthropic Privacy Partner. Zero-retention manuscript processing.

Internal navigation

Where to go next

Open Nature Medicine Guide